| 2024/04/26 22:00:00 | |
|---|---|
| Price | |
| 0.825 USD | |
| Difference | 11.08% (0.08) |
General attributes
| ISIN | US81750R1023 |
| Symbol | MCRB |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 116 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 0.835 USD (1,000) |
| Ask (Ask size) | 0.84 USD (100) |
| Open | 0.7409 USD |
| High | 0.8299 USD |
| Low | 0.74 USD |
| Close (prev. day) | 0.7427 USD |
| VWAP | 0.792499 USD |
| Volume (pcs) | 3,978,538 |
| Trading volume | 3,152,754.99 |
| Number of trades | 10,342 |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/04/26 22:00:00 | |
|---|---|
| Price | |
| 0.825 USD | |
| Difference | 11.08% (0.08) |
General attributes
| ISIN | US81750R1023 |
| Symbol | MCRB |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 116 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 0.835 USD (1,000) |
| Ask (Ask size) | 0.84 USD (100) |
| Open | 0.7409 USD |
| High | 0.8299 USD |
| Low | 0.74 USD |
| Close (prev. day) | 0.7427 USD |
| VWAP | 0.792499 USD |
| Volume (pcs) | 3,978,538 |
| Trading volume | 3,152,754.99 |
| Number of trades | 10,342 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -44.63% | -87.11% | -96.15% |
| Perf (abs.) | -0.67 | -5.58 | -20.60 |
| Beta | 1.49 | 0.58 | 1.27 |
| Volatility | 138.47 | 109.77 | 106.99 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 0.736 USD (5,866,426) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 0.726 USD (4,119,861) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 1.015 USD (4,644,225) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 2.508 USD (3,670,571) |
| YTD High | date | 2.050 USD (2024/01/09) |
| YTD Low | date | 0.540 USD (2024/04/19) |
| 52 Weeks High | date | 6.650 USD (2023/04/27) |
| 52 Weeks Low | date | 0.540 USD (2024/04/19) |
All listings for SERES THERAPEUTICS INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/04/26 | 22:26 | 0.7734 EUR | 0.00 | 2 |
| Stuttgart | 2024/04/26 | 10:32 | 0.6462 EUR | 0.00 | 4 |
| Nasdaq | 2024/04/26 | 22:00 | 0.825 USD | 3.15 | 10,342 |
| Frankfurt | 2024/04/26 | 16:08 | 0.7194 EUR | 0.00 | 3 |
| Duesseldorf | 2024/04/26 | 19:30 | 0.681 EUR | 0.00 | 7 |
| Berlin | 2024/04/26 | 08:03 | 0.6488 EUR | 0.00 | 2 |
Company Profile
| - |
Members of Management Board
| Stephen Berenson | Chairman of Board of Directors |
| Claire Fraser-Liggett | Member of Board of Directors |
| Dennis Ausiello | Member of Board of Directors |
| Willard Dere | Member of Board of Directors |
| Kurt Graves | Member of Board of Directors |
| Paul Biondi | Member of Board of Directors |
| Richard Kender | Member of Board of Directors |